macroautophagi
subsequ
refer
autophagi
conserv
cytosol
degrad
process
eukaryot
maintain
macromolecul
energi
organel
requir
finetun
sequenc
molecular
action
larg
execut
autophagyrel
gene
atg
initi
step
phagophor
consist
doublemembran
sheet
nucleat
amplifi
final
close
form
vesicular
structur
call
autophagosom
engulf
cellular
materi
degrad
accomplish
fusion
autophagosom
ap
lysosom
form
autolysosom
al
recent
emerg
regul
autophagi
cochaperon
bind
protein
fkbp
gener
stressregul
protein
involv
numer
pathway
like
scaffold
regulatori
protein
autophagi
accompani
elev
level
yet
unknown
mechan
multifunct
protein
crucial
autophagi
membran
traffick
mammal
essenti
compon
two
phosphatidylinositol
complex
interact
either
barkor
autophagyrel
key
regul
uvrag
uv
radiat
resistanceassoci
gene
import
initi
nucleat
step
autophagi
wherea
uvrag
contain
complex
function
endocyt
traffick
autophagosom
matur
also
found
matur
autophagosom
enhanc
tether
fusion
autophagosom
regul
posttransl
modif
well
document
particular
involv
phosphoryl
oncogen
kinas
phosphoryl
posit
lead
sequestr
peripher
membran
bind
cytoskeleton
result
inhibit
sever
autophagyregul
kinas
stimulatori
inhibitori
also
target
furthermor
distinct
ligas
differ
type
modifi
complement
ubiquitinspecif
peptidas
usp
depend
site
type
linkag
ubiquitin
autophagi
inhibit
enhanc
underli
mechan
involv
degrad
modul
protein
studi
investig
interplay
autophagi
virus
reveal
virus
use
part
autophagi
machineri
replic
also
evolv
strategi
escap
autophag
degrad
congruent
autophagyinduc
agent
antivir
case
coronavirus
cov
format
replic
complex
doubl
membran
vesicl
dmv
like
infecti
particl
depend
erderiv
membran
thu
current
knowledg
suggest
cov
interact
differenti
compon
autophag
pathway
potenti
util
autophagi
compon
viru
replic
attenu
substanc
inhibit
gener
dmv
shown
broadli
reactiv
cov
replic
importantli
includ
cov
differ
genera
includ
emerg
middl
east
respiratori
syndrom
mer
cov
paradigmat
emerg
viru
entail
consider
pandem
risk
due
preval
dromedari
popul
africa
arabian
pensinsula
transmiss
via
respiratori
tract
caus
sever
form
pneumonia
sinc
discoveri
report
human
merscov
infect
countri
least
fatal
http
wwwwhointemergenciesmerscoven
current
clinicallyapprov
treatment
merscov
infect
hold
promis
broadrang
hostdirect
antivir
target
role
autophagi
merscov
life
cycl
unknown
nevertheless
kinom
analysi
merscovinfect
cell
detect
phosphoryl
chang
sever
regulatori
kinas
includ
mtor
link
autophagi
although
pharmacolog
intervent
broadli
activ
mtorpathway
inhibitor
show
promis
antivir
therapi
sever
virus
includ
identif
downstream
molecul
may
facilit
target
therapeut
approach
put
reduc
side
effect
patient
role
autophagi
suggest
anoth
cov
mous
hepat
viru
mhv
observ
multipl
immun
evas
viru
highli
depend
format
convolut
membran
dmv
reminisc
howev
link
mhv
replic
dmv
appear
involv
autophagi
delet
pivot
autophagi
gene
affect
mhv
note
also
induct
autophagi
starvat
significantli
chang
mhv
hand
result
earlier
studi
employ
knockout
cell
suggest
autophagi
requir
format
dmvbound
mhv
replic
complex
therebi
significantli
enhanc
effici
viral
furthermor
pharmacolog
genet
manipul
autophagi
show
replic
anoth
cov
transmiss
gastroenter
viru
tgev
neg
regul
contrast
anoth
studi
report
enhanc
tgev
replic
thu
gener
role
autophagi
cov
replic
could
establish
yet
aim
elucid
mechan
control
protein
level
find
sphase
kinaseassoci
protein
execut
polyubiquitin
activ
regul
phosphoryl
control
involv
phlpp
small
molecul
inhibitor
enhanc
autophagi
reduc
replic
merscov
point
prospect
therapeut
use
search
mechan
previous
report
increas
pivot
autophagi
regul
driven
consid
effect
mrna
protein
level
direct
comparison
highli
homolog
known
counterplay
increas
level
upon
ectop
fig
regul
protein
stabil
ubiquitinproteasom
system
indic
use
proteasom
inhibitor
increas
level
extent
ubiquitin
fig
supplementari
fig
use
ammonium
chlorid
inhibit
lysosomemedi
proteolysi
confirm
proteasom
degrad
supplementari
fig
ectop
express
similarli
effici
stabilis
proteasom
inhibit
fig
protein
degrad
assay
base
pulsechas
use
halotag
confirm
stabilis
fig
f
result
also
reveal
high
turnov
rate
h
recent
emerg
scaffold
protein
organis
variou
regulatori
protein
thu
consid
associ
ubiquitin
ligas
usp
base
result
interact
first
verifi
associ
usp
ligas
immunoprecipit
cell
fig
known
ligas
interactor
serv
control
interactor
potenti
influenc
polyubiquitin
coimmunoprecipit
cell
reveal
associ
fig
describ
ligas
howev
inhibit
previous
link
induct
sinc
aim
understand
mechan
increas
focuss
follow
protein
found
associ
assess
effect
stabil
monitor
protein
level
addit
translat
inhibitor
cycloheximid
chx
presenc
overexpress
use
control
respect
affect
stabil
lead
faster
proteasom
degrad
ligas
effect
fig
similar
result
obtain
pulsechas
experi
show
reduc
compar
vector
control
alreadi
min
fig
f
corrobor
function
sirna
direct
produc
increas
level
target
along
enhanc
lipid
typic
detect
ratio
fig
supplementari
fig
ectop
express
exert
opposit
effect
fig
supplementari
fig
decreas
sirna
prevent
ubiquitin
fig
addit
stabil
assay
use
either
chx
halotag
establish
reduc
level
sirna
increas
stabil
lead
almost
higher
level
min
fig
next
examin
whether
ubiquitin
ubiquitin
frequent
form
chain
link
sever
ubiquitin
unit
distinct
lysin
k
residu
type
lysin
linkag
determin
protein
fate
use
set
ubiquitin
mutant
found
lead
polyubiquitin
fig
mark
protein
proteasom
use
freeli
avail
massspectrometri
databas
propos
ubiquitin
site
mammalian
mutat
variou
lysin
identifi
ecd
evolutionari
conserv
domain
attach
site
ubiquitin
fig
supplementari
fig
potenti
recruit
rais
question
may
lead
reduc
rather
increas
ubiquitin
sinc
inactiv
kinas
complex
format
phosphatas
regul
phosphoryl
use
ectop
express
coimmunoprecipit
probe
protein
interact
phosphoryl
statu
associ
phlpp
accompani
decreas
phosphoryl
posit
posit
fig
result
suggest
mechan
enact
cascad
activ
chang
recruit
phlpp
fig
follow
sever
approach
substanti
function
cascad
first
employ
mutant
either
mimic
phosphoryl
phosphoryl
phosphomimet
mutant
still
decreas
stabil
mutant
show
effect
fig
c
consist
propos
cascad
fig
made
use
wellestablish
phlpp
led
enhanc
phosphoryl
fig
supplementari
fig
pulsechas
assay
show
stabil
decreas
use
phlpp
inhibitor
fig
f
inhibitor
effect
stabil
ubiquitinationprotect
mutant
corrobor
propos
cascad
fig
h
addit
pharmacolog
inhibit
enhanc
stabil
assay
leav
twice
amount
min
compar
control
fig
order
verifi
reduc
activ
drive
autophagi
cellular
setup
use
sirna
determin
degrad
longliv
target
increas
proteolysi
presenc
autophagi
inhibitor
fig
furthermor
observ
decreas
level
supplementari
fig
typic
goe
along
enhanc
data
consist
inhibitori
effect
autophagi
regul
phosphoryl
cascad
involv
phlpp
next
compar
known
small
molecul
inhibitor
found
increas
stabil
min
exposur
leav
twice
much
min
compar
vehicl
control
p
particular
virtual
degrad
vs
decreas
min
p
compound
effect
fig
supplementari
fig
pulsechas
assay
confirm
effici
compound
stabilis
leav
threefold
protein
min
fig
furthermor
reduc
ubiquitin
effici
fig
last
lane
longliv
protein
assay
reveal
enhanc
protein
halflif
show
effect
fig
starvat
cultiv
cell
hbss
confirm
induc
autophagi
supplementari
fig
elicit
greater
effect
longliv
protein
assay
fig
furthermor
profoundli
affect
also
exampl
blot
fig
quantif
supplementari
fig
establish
marker
autophagi
analys
autophagi
thoroughli
mandatori
includ
assay
address
autophag
protein
turnov
commonli
refer
autophag
thu
subject
flux
assay
specif
inhibitor
vacuolar
h
atpas
bafilomycin
interfer
lysosom
acidif
thu
degrad
autophagosom
reveal
stimulatori
effect
autophag
flux
fig
supplementari
fig
c
addit
shown
oligomer
dimer
tetram
essenti
autophagi
promot
bind
autophagosomelysosom
use
capillarybas
electrophoresi
allow
better
resolut
high
molecular
weight
observ
oligomer
enhanc
supplementari
fig
thu
use
subsequ
experi
result
point
suggest
activ
therebi
autophagi
limit
turn
activ
fig
sinc
merscov
shown
enhanc
phosphoryl
might
reduc
autophagi
infect
cell
merscov
facilit
increas
phosphoryl
fig
supplementari
fig
concomit
decreas
cellular
level
fig
supplementari
fig
enhanc
fig
infect
merscov
led
increas
total
number
phagocyt
vesicl
sum
al
ap
per
cell
fig
howev
number
success
form
al
reduc
significantli
indic
ap
form
fuse
lysosom
cell
infect
fusion
block
also
evidenc
significantli
reduc
oligomer
essenti
aplysosom
infect
cell
fig
f
increas
autophagi
target
supplementari
fig
block
vesicl
fusion
test
use
expect
level
enhanc
upon
treatment
fig
fusion
ap
lysosom
membran
facilit
interact
tsnare
protein
apbound
lysosomebound
interact
mediat
supplementari
fig
coimmunoprecipit
reveal
merscov
infect
lead
reduc
interact
fig
support
conclus
merscov
infect
caus
block
aplysosom
fusion
sinc
result
far
rais
possibl
merscov
may
benefit
reduc
autophagi
gener
cell
knockout
pivot
autophagi
gene
compar
wt
cell
infect
cell
led
format
infecti
viral
particl
fig
genom
viral
rna
copi
increas
fig
effici
format
dmv
requir
cov
replic
might
exploit
autophagi
covinduc
dmv
format
known
depend
viral
nonstructur
protein
nsp
ectop
express
merscov
inde
led
accumul
case
minor
effect
fig
suggest
block
autophag
flux
confirm
use
fig
altogeth
suggest
merscovinduc
inhibit
autophag
flux
mediat
mainli
cov
groupspecif
accessori
protein
modul
viral
replic
immun
assess
potenti
autophagyrel
function
overexpress
merscov
accessori
gene
protein
caus
accumul
enhanc
level
similar
produc
addit
effect
presenc
fig
f
accessori
protein
delet
without
lethal
effect
viru
replic
construct
recombin
merscov
lack
respect
orf
supplementari
fig
b
evalu
effect
autophagi
context
full
viru
replic
comparison
recombin
merscov
variant
show
decreas
accumul
suggest
protein
contribut
inhibit
autophag
flux
supplementari
fig
virus
well
wt
control
viru
grew
higher
level
knockout
vero
cell
compar
wt
cell
supplementari
fig
f
howev
virus
show
overal
decreas
replic
wt
knockout
cell
compar
wt
viru
suggest
attenu
viru
replic
independ
autophagi
influenc
merscov
infect
phosphoryl
degrad
inhibit
autophag
flux
encourag
us
test
inhibitor
may
limit
merscov
amplif
infect
cell
inde
caus
signific
reduct
viral
replic
fig
supplementari
fig
explor
relev
inhibit
viral
infect
gener
term
also
test
sindbi
viru
sinv
replic
known
sinv
induc
autophagi
replic
level
unaffect
observ
treatment
caus
moder
decreas
sinv
replic
supplementari
fig
c
may
thu
exploit
broader
therapeut
antivir
principl
high
concentr
inhibit
cell
mandatori
control
potenti
cell
cycl
effect
cell
may
partli
account
observ
inhibit
merscov
replic
facsbas
analysi
cell
reveal
effect
cell
prolifer
occur
concentr
beyond
supplementari
fig
accordingli
enhanc
level
alreadi
signific
increas
cell
cycl
promot
observ
supplementari
fig
data
strongli
suggest
potenti
mechan
increas
autophagi
reduc
merscov
multipl
correct
way
enhanc
effect
autophagi
elicit
similar
effect
therefor
use
two
recent
introduc
tool
enhanc
function
autophagi
mimet
compound
contrast
chang
level
increas
autophagi
redirect
function
toward
autophagi
pathway
confirm
cell
supplementari
fig
g
enhanc
autophagi
indic
increas
supplementari
fig
g
reduct
supplementari
fig
g
parallel
inhibit
merscov
replic
case
tatb
figur
supplementari
fig
case
pi
supplementari
fig
result
accord
notion
increas
act
enhanc
autophagi
relev
mechan
antivir
effect
vitro
determin
whether
reliev
antagonist
effect
merscov
infect
autophagi
perform
flux
assay
use
either
tandemlabel
chang
lipid
infect
cell
evidenc
constant
level
absenc
fig
gray
bar
increas
presenc
supplementari
fig
fluorescencebas
assay
reveal
enhanc
number
ap
decreas
number
al
fig
c
furthermor
enhanc
oligomer
fig
e
interact
autophag
snare
complex
protein
merscov
infect
cell
fig
therebi
counteract
effect
merscov
see
fig
thu
inhibit
merscov
product
like
enhanc
level
might
also
account
effect
late
step
sinc
littl
interact
detect
use
immunoprecipit
effect
may
requir
interact
result
encourag
us
test
potenti
inhibitor
autophagyinduc
fdaapprov
drug
drug
clinic
trial
particular
interest
could
becom
readili
avail
treatment
human
note
valinomycin
val
shown
target
sarscov
also
known
act
chosen
drug
tabl
niclosamid
nic
val
effici
enhanc
autophag
flux
fig
supplementari
fig
b
supplementari
tabl
compar
see
fig
f
supplementari
fig
f
nic
val
reduc
merscov
multipl
h
pi
fig
supplementari
fig
thu
nic
val
character
drug
enhanc
oligomer
twofold
supplementari
fig
e
increas
number
autolysosom
twofold
supplementari
fig
g
nic
also
affect
autophag
flux
infect
cell
similar
supplementari
fig
therefor
three
compound
test
doseeffect
relationship
merscov
infect
experi
compound
show
high
efficaci
fold
imaxn
fold
imaxv
fold
fig
supplementari
fig
moder
high
potenc
nm
present
work
reveal
target
ligas
execut
ubiquitin
result
proteasom
degrad
action
counteract
regul
phosphoryl
form
regulatori
complex
phlpp
inhibit
increas
level
enhanc
assembl
lysosom
snare
protein
autophagi
effici
reduc
replic
merscov
fig
pivot
element
molecular
feedback
loop
cellular
physiolog
stress
reaction
increasingli
emerg
scaffold
chaperon
variou
regulatori
protein
appear
recruit
inact
form
probabl
virtu
interact
kinas
phosphatas
phlpp
similarli
protein
interact
increas
decreas
phosphoryl
activ
thu
impact
least
via
two
mechan
phosphoryl
regulatori
ligas
mechan
involv
exhibit
yet
anoth
way
influenc
phosphoryl
remov
ubiquitin
addit
polyubiquitin
undergo
ubiquitin
also
ligas
differ
site
differ
type
polyubiquitin
produc
yet
determin
site
decor
noncanon
ubiquitin
lead
proteasom
ubiquitin
domain
enhanc
autophagi
possibl
reduc
interact
anoth
posit
regul
substrat
receptor
ligas
form
ubiquitin
chain
enhanc
associ
thu
stimul
activ
autophagi
promot
lipid
sum
activ
regul
ubiquitin
multipl
way
stimulatori
inhibitori
recent
polyq
domain
protein
ataxin
shown
interact
remov
polyubiquitin
activ
competit
inhibit
longer
polyq
mutat
diseas
togeth
herepres
discoveri
ligas
point
intrigu
possibl
inhibit
use
small
molecul
inhibitor
might
counteract
deleteri
effect
solubl
protein
polyq
expans
held
respons
caus
neurodegen
diseas
huntington
diseas
ataxin
spinocerebellar
due
tremend
variabl
viral
protein
huge
interest
host
cellencod
pathway
could
exploit
fight
viral
infect
present
studi
well
earlier
work
suggest
autophagi
pivot
compon
virushost
interact
potenti
broadrang
antivir
merscov
replic
remain
elucid
whether
block
basal
autophagi
mandatori
auxiliari
nevertheless
viru
encod
least
three
protein
limit
autophagi
express
ectop
although
detail
molecular
mechan
yet
analys
merscov
may
also
play
role
inhibit
expans
autophagosom
shown
merscov
phosphodiesteras
function
inhibit
activ
rnase
l
activ
merscov
locat
endoplasm
reticulumgolgi
intermedi
shown
inhibit
ifnbeta
may
constitut
anoth
link
delet
result
reduc
merscov
growth
result
differ
previou
observ
may
relat
differ
cell
line
cdna
clone
construct
addit
use
low
moi
type
ifndefici
cell
line
allow
determin
minor
growth
differ
absenc
merscov
replic
may
also
result
lower
level
compar
merscov
wildtypeinfect
also
mockinfect
control
cell
point
complex
interact
viru
replic
autophagi
may
counteract
respons
host
viral
infect
function
relev
link
autophagi
requir
investig
appar
sever
cov
protein
collabor
reprogram
membran
traffic
cell
dmv
format
serv
compart
viral
genom
replic
sinc
autophagi
tightli
link
intracellular
membran
traffic
turnov
appear
possibl
merscov
block
autophagi
evad
degrad
also
improv
membran
avail
appear
potenti
treatment
aris
observ
reduct
viral
replic
upon
autophagi
stimul
easili
applic
vivo
side
effect
ineffici
peptid
exampl
rapamycin
vitamin
restrict
replic
hiv
primari
human
autophagyinduc
peptid
limit
replic
number
virus
present
result
therapeut
induct
autophagi
inhibit
emerg
promis
approach
note
substanc
test
may
addit
target
exclud
possibl
compound
addit
target
respons
antivir
effect
consid
scenario
less
like
assess
also
base
observ
antivir
effect
compound
target
establish
client
nevertheless
futur
experi
assess
effect
drug
autophagydefect
cell
knockout
cell
remain
investig
whether
inhibit
affect
autophagysensit
virus
sinv
overtli
influenc
knockout
despit
indic
degrad
viral
compon
react
modestli
reason
unknown
may
relat
involv
immun
pathway
influenc
sinv
exampl
jakstat
stress
granul
autophagi
function
absenc
fdaapprov
drug
known
act
inhibitor
show
drug
effect
reduc
merscov
replic
vitro
exampl
niclosamid
pyrvinium
pamoat
even
though
report
low
absorpt
other
found
consider
absorpt
serum
level
niclosamid
reach
concentr
show
effici
limit
merscov
replic
addit
inhal
formul
niclosamid
compound
also
may
potenti
infect
clinic
condit
influenc
autophagi
follow
chemic
use
treatment
cell
alfa
aeser
sigmaaldrich
sigmaaldrich
ami
sigmaaldrich
bro
sigmaaldrich
cel
sigmaaldrich
clo
sigmaaldrich
eto
sigmaaldrich
met
sigmaaldrich
par
sigmaaldrich
rap
tocri
tocri
selleckchem
tatb
anaspec
tatscr
anaspec
go
sigmaaldrich
hal
tocri
min
sigmaaldrich
nic
sigmaaldrich
pim
sigmaaldrich
prt
tocri
per
sigmaaldrich
pep
sigmaaldrich
pyr
sigmaaldrich
ra
sigmaaldrich
sec
sigmaaldrich
sal
sigmaaldrich
tam
sigmaaldrich
top
tocri
val
sigmaaldrich
phlppi
glixxlab
perkin
elmer
akti
x
cayman
chemic
hcl
cayman
chemic
coip
endogen
perform
cell
pbswash
cell
pellet
incub
dss
disuccinimidyl
subern
thermo
fisher
scientif
correspond
vehicl
dmso
pb
crosslink
perform
min
room
temperatur
follow
h
rotat
wash
pb
crosslink
quench
trisbuff
salin
ph
min
cell
lyse
coipbuff
contain
mm
trishcl
ph
mm
nacl
mm
edta
igep
complement
proteas
inhibitor
cocktail
sigma
follow
incub
overhead
shaker
min
mg
lysat
incub
antibodi
overnight
bsablock
protein
g
dynabead
invitrogen
ad
mix
follow
h
incub
bead
wash
three
time
pb
proteinantibodi
complex
elut
boil
min
laemmli
load
buffer
fifteen
microgram
cell
lysat
immunoprecipit
separ
sdspage
ldh
assay
assess
membran
disrupt
cell
death
releas
lactat
dehydrogenas
ldh
growth
medium
cell
measur
assay
ldh
cytotox
detect
system
carri
accord
manufactur
protocol
clontech
mountain
view
ca
usa
posit
control
triton
ad
medium
h
prior
perform
assay
empti
well
use
medium
neg
control
mtt
assay
cell
incub
presenc
mg
tetrazol
bromid
mtt
h
readout
mtt
assay
carri
describ
protein
extract
obtain
lyse
cell
ripa
buffer
mm
nacl
igep
sodium
deoxychol
sd
mm
tri
freshli
supplement
proteas
inhibitor
merck
millipor
darmstadt
germani
benzonas
merck
millipor
mm
dtt
sigma
aldrich
munich
germani
phosphatas
inhibitor
roch
penzberg
germani
inhibitor
cocktail
protein
separ
sdspage
electrotransf
onto
nitrocellulos
membran
blot
place
trisbuff
salin
supplement
tween
sigma
aldrich
nonfat
milk
h
room
temperatur
incub
primari
antibodi
dilut
tween
overnight
follow
primari
antibodi
use
actin
santa
cruz
biotechnolog
cell
signal
technolog
specif
polyubiquitin
rabbit
mab
cell
signal
cell
signal
technolog
cell
signal
technolog
cell
signal
technolog
cell
signal
technolog
cell
signal
technolog
sigma
aldrich
sigma
aldrich
millipor
antibodi
recogn
kind
gift
cell
signal
subsequ
blot
wash
probe
respect
horseradish
peroxidas
fluorophoreconjug
secondari
antibodi
h
room
temperatur
immunoreact
band
visual
either
use
ecl
detect
reagent
millipor
billerica
usa
directli
excit
respect
fluorophor
determin
band
intens
perform
biorad
chemidoc
mp
case
oligomer
lysat
analyz
capillari
electrophoresi
proteinsimpl
use
kda
cartridg
gener
protein
quantif
perform
normal
intens
actin
determin
membran
quantif
lipid
intens
alway
refer
signal
intens
correspond
follow
guidelin
determin
whole
cell
lysat
prepar
ripa
lysi
buffer
contain
mm
nacl
igep
sodium
deoxychol
sd
mm
tri
ph
proteinas
inhibitor
cocktail
iii
calbiochem
benzonas
novagen
dithiothreitol
mm
phosphataseinhibitor
phosphostop
roch
freshli
ad
cell
lysi
supernat
discard
cell
care
rins
precool
pb
precool
pb
ad
cell
scrape
transfer
microcentrifug
tube
cell
pellet
centrifug
g
min
supernat
remov
care
cell
resuspend
ripa
lysi
buffer
incub
min
effici
lysi
sd
load
buffer
nupag
ld
thermofish
scientif
ad
sampl
boil
min
sampl
store
process
indic
respect
section
dsmz
german
collect
microorgan
cell
cultur
cultiv
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
penicillinstreptomycin
nonessenti
amino
acid
lglutamin
sodium
pyruv
cell
atcc
manassa
va
usa
cultiv
dmem
supplement
fb
penicillinstreptomycin
sodium
pyruv
transfect
detach
resuspend
mm
hepe
ph
mm
nacl
mm
kcl
mm
transfect
use
nucleofector
ii
system
program
vero
plate
plate
cell
densiti
medium
transfect
lipofectamin
accord
manufactur
protocol
knockout
plasmid
contain
grna
sequenc
purchas
genscript
use
fortyeight
transfect
puromycin
invivogen
ad
medium
h
medium
chang
puromycinfre
medium
anoth
h
later
cell
sort
plate
densiti
one
cell
per
well
use
bd
facsmelodi
cell
sorter
bd
bioscienc
cell
maintain
condit
medium
week
coloni
form
singl
cell
coloni
trypsin
expand
individu
knockout
examin
clone
western
blot
analysi
use
purchas
santa
cruz
viru
infect
cell
seed
concentr
cell
h
viru
stock
dilut
serumfre
medium
accord
desir
moi
viru
adsorpt
ml
sixwel
viru
master
mix
ad
cell
incub
h
compar
noninfect
cell
heatinactiv
min
viru
use
mock
control
h
viru
dilut
remov
well
wash
twice
pb
refil
dmem
supplement
describ
sampl
taken
indic
time
point
viru
infect
experi
conduct
biosafeti
level
condit
enhanc
respiratori
person
protect
equip
sinv
infect
experi
strain
use
sinv
infect
done
use
cell
appli
moi
h
appli
concentr
genom
equival
determin
realtim
rtpcr
therefor
cell
supernat
lyse
lysi
buffer
macherey
nagel
heat
min
viru
inactiv
viral
rna
extract
accord
manufactur
instruct
realtim
rtpcr
assay
perform
specif
upe
assay
appli
detect
merscov
genom
equival
assay
use
detect
genom
equival
primer
upefwd
uperev
nm
probe
upeprb
fam
ctcttcacataa
n
n
tamra
well
tcacaccagttga
aaatcctaattg
probe
fam
cccgtaat
g
n
n
tamra
quantif
primer
forward
revers
use
describ
sinv
infecti
particl
quantifi
plaqu
titrat
cell
previous
minor
modif
briefli
monolay
seed
plate
incub
sinvcontain
cell
cultur
supernat
overlaid
avicel
mem
contain
fc
penicillinstreptomycin
h
h
h
plaqu
fixat
visual
stain
crystal
violet
count
heterolog
express
pcr
amplifi
merscov
cdna
clone
eukaryot
express
plasmid
pcagg
along
ctermin
flag
tag
tatcacttgtcatcgtcgtccttgtagtcgccggcctgcatagcagcaacctttaa
construct
plasmid
express
accessori
open
read
frame
orf
previous
construct
merscov
cdna
clone
lack
accessori
orf
accessori
orf
delet
use
twostep
markerless
red
recombin
system
extens
briefli
first
step
kanamycin
resist
gene
amplifi
overhang
extens
pcr
pepkan
vector
kindli
provid
k
tischer
k
osterried
primer
contain
homolog
merscov
recombin
site
desir
mutat
iscei
restrict
site
cgcgcaaagcgaggaagaggagccattctcaactaatgatgttgtctccatacgg
gtttattaccctgattggaagaccgtatggagacaacatcattagttggagaatg
tcccattttacatcatccaggattttaacgaactgcagctctgcgctactatggta
tacacgggacccatagtagcgcagagctgcagttcgttaaaatcctggatgccag
would
like
point
design
preserv
regulatori
site
contrast
previou
rational
preserv
equal
number
subgenom
mrna
e
coli
cell
kindli
provid
k
tischer
k
osterried
contain
merscov
cdna
clone
transfect
pcr
product
order
induc
recombin
transfer
construct
merscov
backbon
second
step
kanamycin
select
marker
excis
induc
vivo
iscei
cleavag
second
red
recombin
event
rescu
stock
product
recombin
virus
perform
describ
follow
express
construct
use
experi
perform
cultur
cell
addgeneorg
addgeneorg
addgeneorg
addgeneorg
addgeneorg
addgeneorg
promega
addgeneorg
addgeneorg
addgeneorg
addgeneorg
fl
addgeneorg
phosphomimet
phosphonul
mutant
kind
gift
author
transfect
construct
led
appear
anoth
band
higher
molecular
weight
western
blot
irrespect
exact
natur
band
specif
coprecipit
observ
band
predict
molecular
weight
fig
absent
coprecipit
fig
figur
b
display
band
predict
molecular
weight
cell
electropor
describ
sens
antisens
control
sirna
sens
antisens
harvest
h
primer
purchas
biomol
hamburg
germani
determin
effect
drug
treatment
merscov
infect
autophag
flux
either
alfa
aeser
specif
inhibitor
vacuolar
hatpas
interf
lysosom
acidif
therebi
degrad
autophagosom
cargo
use
transfect
plasmid
addgeneorg
express
tag
gfp
inactiv
autolysosom
mrfp
resist
inactiv
autolysosom
follow
recent
updat
guidelin
monitor
transfect
cell
perform
use
fugen
transfect
reagent
promega
follow
merscov
infect
moi
drug
treatment
next
day
cell
fix
pfa
h
day
later
analyz
laser
scan
microscopi
leica
confoc
vesicl
count
experiment
blind
condit
experi
perform
describ
klionski
et
cell
incub
valin
overnight
chase
fresh
media
excess
valin
overnight
incub
h
complet
medium
starvat
media
hbssebss
mm
hepe
starv
check
protein
degrad
measur
due
autophag
process
experi
also
perform
presenc
mm
typic
use
inhibit
llp
degrad
monitor
h
transfect
cell
incub
chx
express
construct
empti
vector
addgeneorg
addgeneorg
use
stimul
transfect
cell
cell
transfect
express
construct
pulsechas
assay
perform
accord
manufactur
manual
use
halogen
fluorophor
nm
promega
overnight
puls
follow
switch
cell
medium
without
dye
chase
estim
maxim
viral
inhibit
imax
drug
concentr
achiev
viral
inhibit
halfway
baselin
maximum
first
normal
doserespons
curv
drug
divid
cell
viabil
fit
normal
viral
inhibit
curv
sigmoid
curv
use
sigmoid
nonlinear
least
squar
function
r
version
http
wwwrprojectorg
previous
describ
http
base
sigmoidfit
curv
determin
numer
imax
cell
wash
pb
fix
cold
ethanol
min
wash
pb
cell
treat
ribonucleas
sigma
aldrich
stain
vybrant
dyecycl
orang
invitrogen
describ
manufactur
manual
cell
analyz
facscalibur
bd
bioscienc
acquir
data
analyz
flowjo
softwar
tree
star
two
group
compar
student
ttest
appli
three
group
comparison
one
twoway
analysi
varianc
anova
perform
appropri
follow
tukey
bonferroni
post
hoc
test
appropri
ttest
pvalu
anova
f
pvalu
report
legend
supplementari
figur
signific
result
contrast
test
indic
asterisk
graph
statist
test
twotail
p
consid
statist
signific
complet
set
raw
data
see
data
sourc
file
inform
research
design
avail
natur
research
report
summari
link
articl
